| pubmed-article:15269606 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C0010802 | lld:lifeskim |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:15269606 | lifeskim:mentions | umls-concept:C0053355 | lld:lifeskim |
| pubmed-article:15269606 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:15269606 | pubmed:dateCreated | 2004-7-22 | lld:pubmed |
| pubmed-article:15269606 | pubmed:abstractText | A 65-year-old man was diagnosed with chronic myeloid leukemia (CML) in February 1990, and was treated with busulfan and ubenimex. Cytogenetic analysis of the bone marrow revealed the Philadelphia (Ph) chromosome in 100% of cells of analyzed at diagnosis. Treatment with busulfan was stopped in March 1993 due to bone marrow suppression. The Ph chromosome was seen in 80% of cells in June 1993. He received ubenimex monotherapy after cessation of busulfan. Complete disappearance of the Ph chromosome was confirmed in May 1995 and has continued to date. This suggests that ubenimex might specifically affect the Ph chromosome and be useful as maintenance therapy for CML. | lld:pubmed |
| pubmed-article:15269606 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15269606 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15269606 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15269606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15269606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15269606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15269606 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15269606 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15269606 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15269606 | pubmed:issn | 0959-4973 | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:KanamoriHeiwa... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:IshigatsuboYo... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:FujimakiKatsu... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:TaguchiJunJ | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:YamajiSatoshi... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:TakabayashiMa... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:TakasakiHirot... | lld:pubmed |
| pubmed-article:15269606 | pubmed:author | pubmed-author:KoharazawaHid... | lld:pubmed |
| pubmed-article:15269606 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15269606 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:15269606 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15269606 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15269606 | pubmed:pagination | 729-31 | lld:pubmed |
| pubmed-article:15269606 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:meshHeading | pubmed-meshheading:15269606... | lld:pubmed |
| pubmed-article:15269606 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15269606 | pubmed:articleTitle | Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia. | lld:pubmed |
| pubmed-article:15269606 | pubmed:affiliation | First Department of Internal Medicine, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan. heiwak@med.yokohama-cu.ac.jp | lld:pubmed |
| pubmed-article:15269606 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15269606 | pubmed:publicationType | Case Reports | lld:pubmed |
